Showing 1371-1380 of 9922 results for "".
Driving Practice Value: The Competitive Sale Process
https://practicaldermatology.com/topics/practice-management/driving-practice-value-the-competitive-sale-process/24007/Successful Meetings: It's All About the Follow-up
https://practicaldermatology.com/topics/practice-management/successful-meetings-its-all-about-the-follow-up/20456/Frustrated by meetings that are run well but produce limited results? Then try keeping an eye on what happens afterwards.Long-term Management Strategies for AD, Melasma, and More
https://practicaldermatology.com/topics/psoriasis/long-term-management-strategies-for-ad-melasma-and-more/20801/After the acute treatment phase, experts urge a long-view on management.Cutaneous Signet Ring Squamous Cell Carcinoma: Case Presentation and Brief Literature Review
https://practicaldermatology.com/programs/practical-dermatology/cutaneous-signet-ring-squamous-cell-carcinoma-case-presentation-and-brief-literature-review/24026/An in-depth look at the clinical presentation of this rare tumor type.Energy-Based Devices You Should Have On Your Radar
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/energy-based-devices-you-should-have-on-your-radar/23646/Here’s a look at technologies that may play a key role in patient management this year and beyond.Coming Soon: New Biopsy Codes
https://practicaldermatology.com/topics/general-topics/coming-soon-new-biopsy-codes/20411/Is your practice prepared for changes to the CPT codes?Use of Hylenex to Treat Microstomia in CREST Syndrome: A Case Study and Call to Action
https://practicaldermatology.com/youngmd-connect/resident-resource-center/proton-pump-inhibitor-induced-dermal-hypersensitivity-reaction-masquerading-as-an-arthropod-bite-reaction/23915/DermWireTV: Allē Launches; Arazlo Cleared; BTL Files Suit
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-alle-launches-arazlo-cleared-btl-files-suit/19714/More than 10 Years and 6 million members later, the Brilliant Distinctions program is being relaunched with a new name and a new app: Allē. Arazlo Lotion 0.045%, the first lotion formulation of tazarotene, is now FDA approved for the topical treatment of acne vulgaris in patients nine years of age aMind Your Business: Exploring the Mind/Skin Connection
https://practicaldermatology.com/topics/general-topics/mind-your-business-exploring-the-mindskin-connection/20754/Dermatologists and mental health professionals can join forces to treat the whole patient.Infantile Hemangioma with Minimal or Arrested Growth with Superimposed Eczematous Dermatitis and Bacterial Infection: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/infantile-hemangioma-with-minimal-or-arrested-growth-with-superimposed-eczematous-dermatitis-and-bacterial-infection-a-case-report/23602/